Carlos A. Guzmán

Darío Lirussi¹, 

Thomas Ebensen¹, 

Kai Schulze¹, 

Elena Reinhard¹, 

Stephanie Trittel¹, 

Peggy Riese¹, 

Blair Prochnow¹, 

Carlos A. Guzmán¹ 

¹Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research 

Carlos Victor Montefusco-Pereira^*,1,2, 

Justus C. Horstmann^*,1,2, 

Thomas Ebensen³, 

Christoph Beisswenger⁴, 

Robert Bals⁴, 

Carlos A. Guzmán³, 

Nicole Schneider-Daum¹, 

Cristiane de Souza Carvalho-Wodarz¹, 

Claus-Michael Lehr^1,2 

¹Department of Drug Delivery, Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), 

²Department of Pharmacy, Saarland University, 

³Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research, 

⁴Department of Internal Medicine V - Pulmonology, Allergology, Respiratory Intensive Care Medicine, Saarland University Hospital